Spatial memory impairment is associated with decreased dopamine-β-hydroxylase activity in the brains of rats exposed to manganese chloride

Valentina Mikhailovna Kudrinskaya Andrey Pavlovich Ivlev Daria Alexeevna Obukhova Viktoriya Aleksandrovna Maystrenko Tatiana Valentinovna Tiutiunnik Dmitrii Sergeevich Traktirov Marina Nikolaevna Karpenko Irina Sergeevna Ivleva a Department of Physiology (Pavlov's),Institute of Experimental Medicine,St. Petersburg,Russiab Sechenov Institute of Evolutionary Physiology and Biochemistry Russian Academy of Sciences,St. Petersburg,Russia
DOI: https://doi.org/10.1080/15376516.2024.2379012
2024-07-18
Toxicology Mechanisms and Methods
Abstract:Chronic exposure to manganese compounds leads to accumulation of the manganese in the basal ganglia and hippocampus. High levels of manganese in these structures lead to oxidative stress, neuroinflammation, imbalance of brain neurotransmitters, and hyperactivation of calpains mediating neurotoxicity and causing motor and cognitive impairment. The purpose of this work was to study the effect of excess manganese chloride intake on rats' spatial memory and on dopamine-β-hydroxylase (DβH) activity under conditions of calpain activity suppression. Rats were divided into 3 groups of 10 animals each. Group 1 received MnCl 2 (30 days, 5 mg/kg/day, intranasally), group 2 received MnCl 2 (30 days, 5 mg/kg/day, intranasally) and calpain inhibitor Cast (184–210) (30 days, 5 μg/kg/day, intranasally), and group 3 received sterile saline (30 days in a volume of 20 μl, intranasally). The spatial working memory was assessed using Morris water maze test. DβH activity was determined by HPLC. We have shown that in response to excessive intake of MnCl 2 , there was a development of cognitive impairments in rats, which was accompanied by a decrease in DβH activity in the hippocampus. The severity of cognitive impairment was reduced by inhibiting the activity of m-calpain. The protective effect of calpain inhibitors was achieved not through an effect on DβH activity. Thus, the development of therapeutic regimens for the treatment of manganism using dopaminomimetics and/or by inhibiting calpains, must be performed taking into account the manganese-induced decrease of DβH activity and the inability to influence this process with calpain inhibitors.
toxicology
What problem does this paper attempt to address?